LEADER 03739nam 22009613u 450 001 996339118303316 005 20221205215803.0 010 $a1-280-75121-5 010 $a9786610751211 010 $a1-84692-560-6 035 $a(CKB)1000000000554195 035 $a(EBL)362702 035 $a(OCoLC)476194135 035 $a(SSID)ssj0000258329 035 $a(PQKBManifestationID)12096163 035 $a(PQKBTitleCode)TC0000258329 035 $a(PQKBWorkID)10272937 035 $a(PQKB)11188249 035 $a(MiAaPQ)54800 035 $a(EXLCZ)991000000000554195 100 $a20130418d2006|||| u|| | 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aTherapeutic Strategies in Dementia$b[electronic resource] 210 $aOxford $cAtlas Medical Publishing Ltd$d2006 215 $a1 online resource (358 p.) 225 1 $aTherapeutic Strategies 300 $aDescription based upon print version of record. 311 $a1-904392-58-X 327 $aContents; Contributors; Foreword; Preface; Section I: Current pharmacological approaches in dementia; Section II: Biological developments and future therapies; Section III: Management of non-cognitive issues in dementia; Section IV: Treatment of non-Alzheimer's disease cognitive impairment; Abbreviations; Index 330 $aWidely acknowledged as one of the most challenging aspects of dealing with an ageing population, the increasing prevalence of cognitive decline in the elderly presents the clinician with a variety of complex therapeutic problems. Alzheimer's disease and other dementias vary in their onset and progression, as do patients in their responsiveness to treatment. Social management is as important as the choice of therapeutic agent, and implementing effective and sympathetic treatment requires care and sensitivity as well as a sound knowledge of currently available options. In this important new work 410 0$aTherapeutic Strategies 606 $aAlzheimer's disease -- Popular works 606 $aAlzheimer's disease 606 $aDementia -- Popular works 606 $aDementia 606 $aAlzheimer Disease 606 $aCentral Nervous System Agents 606 $aDementia 606 $aTauopathies 606 $aBrain Diseases 606 $aDelirium, Dementia, Amnestic, Cognitive Disorders 606 $aTherapeutic Uses 606 $aPharmacologic Actions 606 $aCentral Nervous System Diseases 606 $aMental Disorders 606 $aNeurodegenerative Diseases 606 $aNervous System Diseases 606 $aChemical Actions and Uses 606 $aDiseases 615 4$aAlzheimer's disease -- Popular works. 615 4$aAlzheimer's disease. 615 4$aDementia -- Popular works. 615 4$aDementia. 615 2$aAlzheimer Disease 615 2$aCentral Nervous System Agents 615 2$aDementia 615 2$aTauopathies 615 2$aBrain Diseases 615 2$aDelirium, Dementia, Amnestic, Cognitive Disorders 615 2$aTherapeutic Uses 615 2$aPharmacologic Actions 615 2$aCentral Nervous System Diseases 615 2$aMental Disorders 615 2$aNeurodegenerative Diseases 615 2$aNervous System Diseases 615 2$aChemical Actions and Uses 615 2$aDiseases 676 $a616.8/31 676 $a616.831 700 $aRitchie$b CW$01016311 701 $aAmes$b D$01016312 701 $aMasters$b CL$01016313 801 0$bAU-PeEL 801 1$bAU-PeEL 801 2$bAU-PeEL 906 $aBOOK 912 $a996339118303316 996 $aTherapeutic Strategies in Dementia$92377463 997 $aUNISA